SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

ArQule Inc. (ARQL)

ARQL RSS Feed
Add ARQL Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 9/28/2016 8:28:55 PM - Followers: 34 - Board type: Free - Posts Today: 0

http://www.arqule.com/

http://finance.yahoo.com/q/h?s=ARQL

http://library.corporate-ir.net/library/82/829/82991/items/251342/ArQuleJune07.pdf

http://www.clinicaltrials.gov/ct/search;jsessionid=6800B95BD4EAC4F758634AECE97FE6F8?term=arqule

ArQule, Inc., a clinical-stage biotechnology company, engages in the research and development of cancer therapeutics directed toward molecular targets. Its lead product ARQ 197 is an orally administered inhibitor of the c-Met receptor tyrosine kinase, which is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in microphthalmia transcription factor associated tumors, non-small cell lung cancer, pancreatic adenocarcinoma, and hepatocellular carcinoma. The company?s clinical stage products also include ARQ 501, ARQ 761, and ARQ 171, which are designed to kill cancer cells selectively while sparing normal cells through the direct activation of DNA damage response/checkpoint pathways. It?s preclinical and discovery programs comprise ARQ 621 focused on inhibition of the Eg5 kinesin spindle protein; ARQ 761, a second-generation E2F-1 activator; and BRAF and AKIP Kinase inhibitors. The company has collaborations with Kyowa Hakko Kirin Co., Ltd. and Daiichi Sankyo Co., Ltd. ArQule, Inc. was founded in 1993 and is headquartered in Woburn, Massachusetts.

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ARQL
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ARQL News: Securities Registration Statement (simplified Form) (s-3/a) 09/23/2016 04:32:12 PM
ARQL News: Statement of Changes in Beneficial Ownership (4) 09/22/2016 11:38:59 AM
ARQL News: Statement of Changes in Beneficial Ownership (4) 09/22/2016 11:38:59 AM
ARQL News: ArQule to Present at The Leerink Partners Rare Disease and Immuno-Oncology Roundtable on September 28, 2016 09/21/2016 07:00:00 AM
ARQL News: ArQule Announces Publication of Manuscript Highlighting Preclinical Activity of FGFR Inhibitor, ARQ 087, in Peer Reviewed Jou... 09/15/2016 07:00:00 AM
PostSubject
#223   Got in today. Could be getting ready simba1 09/28/16 08:28:55 PM
#222   ARQL Strong uptrend developing. Watch out when it gogoyears 09/26/16 10:57:33 PM
#221   That was released/reported about 6 months ago gogoyears 09/23/16 04:54:32 PM
#220   Where do you see Pfizer? etradeedge 09/23/16 04:26:45 PM
#219   In at 1.45 NathanH 08/30/16 08:13:21 PM
#218   ARQL is caught in the lull before news. gogoyears 08/20/16 09:42:52 AM
#217   I would like to see $2.10 and above jbem777 06/24/16 07:08:11 PM
#216   What's your price target here? Tons of potential imo Bulldog88 06/23/16 03:49:56 PM
#215   This is set to rip in the next jbem777 06/22/16 08:50:34 PM
#214   Added more today. Multiple catalysts this year, with blackdeath 06/22/16 02:35:04 PM
#213   BOOM# CHACCA LACCA gogoyears 06/22/16 01:26:13 AM
#212   New report issued from rising tide equity research blackdeath 06/20/16 11:37:22 AM
#211   ARQL Added more today. Looking forward to next gogoyears 04/29/16 05:21:44 PM
#210   400K block @ $1.80 NY1972 04/20/16 01:26:58 PM
#209   ARQ761 in combination with anti-CTLA4 or anti-PD-L1??? NY1972 04/18/16 09:38:22 PM
#208   combination of a FGFR inhibitor with an AKT NY1972 04/16/16 04:39:50 PM
#207   PARP inhibitor olaparib (Ola) and AKT inhibitor AZD5363 NY1972 04/16/16 04:36:00 PM
#206   ARQL This trail has also been approved to gogoyears 03/25/16 07:57:01 AM
#205   Insiders are buying....pfizer just took a small position camvvv 03/22/16 01:38:02 PM
#204   Insiders are buying....pfizer just took a small position camvvv 03/22/16 01:38:01 PM
#203   2016 will be the year for Arqule. We gogoyears 12/18/15 10:11:51 PM
#202   Set to move. Announcements coming. RealWins 11/29/15 10:20:28 AM
#201   ARQL PSL all over this one! Explosive set Strukture 09/20/15 02:53:29 PM
#200   I became a shareholder yesterday. Could be a Mitshu35 06/11/15 03:37:31 PM
#199   Best volume I've seen in a long time, Xjtfo05 04/29/15 11:57:20 AM
#197     Lucky Moneysauce 02/26/15 04:56:28 PM
#196   Buying into several small cap biotechs like ARQL surf1944 10/23/14 11:21:36 AM
#195   For anyone following this board or the phase texansx5 09/19/14 05:09:57 PM
#194   Deleted from the Russell 3000. RealGenius 06/30/14 12:09:45 AM
#193   look like a real solid bottom and starting CaptainCanada 06/25/14 10:12:38 PM
#192   Loaded up this morning. Lucky Moneysauce 03/12/14 06:13:38 PM
#191   8:07AM ArQule announces commencement of Phase 3 clinical surf1944 02/04/14 09:24:50 AM
#190   BUY, BUY, BUY.... QHP 01/17/14 09:03:03 AM
#189   ARQL SELL SELL SELL SHORT THIS BLOATED POS!!!!! Stockexpertpro 01/17/14 08:59:22 AM
#188   ARQL a/h trading hi= $4.36 [SMART MONEY] 01/16/14 08:20:45 PM
#187   That's a pleasant surprise! Looking forward to new bikaver 01/16/14 08:18:23 PM
#186   See me for shares in the A.M!!!!!!! :) Fast Flyer 03 01/16/14 07:32:54 PM
#185   Going beyond year high in AH! Fast Flyer 03 01/16/14 07:30:25 PM
#184   Big News! DITRstocks 01/16/14 05:54:56 PM
#183   ArQule Provides Updates on Clinical Trials in Hepatocellular [SMART MONEY] 01/16/14 04:33:04 PM
#182   ARQL hits $3.36 on NEW$ [SMART MONEY] 01/16/14 04:28:33 PM
#181   7:03AM ArQule beats by $0.03, beats on revs surf1944 11/07/13 09:34:43 AM
#180   8:44AM ArQule: Data presented at European cancer congress surf1944 09/30/13 09:47:14 AM
#179   Took some ARQL off the table on this surf1944 09/27/13 09:52:24 AM
#178   In ARQL @ 2.22 bikaver 09/09/13 08:12:32 PM
#177   $ARQL ~ Daily Par Sar Buy Signal ~ Penny Roger$ 08/22/13 07:25:56 AM
#176   7:12AM ArQule beats by $0.01, beats on revs surf1944 07/30/13 09:08:01 AM
#175   1:42AM ArQule presents Phase 2 study results for surf1944 06/03/13 09:44:17 AM
#174   7:01AM ArQule beats by $0.02, beats on revs surf1944 05/08/13 10:12:01 AM
#173   Here you are again surf1944- THis stock noretreat 04/29/13 07:19:51 AM
PostSubject